GOAL-Directed ANalgesia (GOALDAN) (GOALDAN)
Immediate Severe Postoperative Pain, Perioperative Hemodynamic
About this trial
This is an interventional prevention trial for Immediate Severe Postoperative Pain focused on measuring prospective, single blind, multicenter, randomized, controlled, Analgesia Nociception Index (ANI), Postoperative pain
Eligibility Criteria
Inclusion Criteria:
- 18≤ Age <65 years old
- Patient operated on a scheduled surgery under general anesthesia
- Patient with a American Society of Anesthesiologists (ASA) score of I to III
- Patient having given his consent in the manner described in Article L1122-1-1 of the Public Health Code
- Patient affiliated with a social security regimen or beneficiary of such a regimen
Exclusion Criteria:
- general anesthesia without extubating (laryngeal mask)
- neuraxial preoperative regional anesthesia (epidural or rachianalgesia)
- opioid-free anesthesia
- preoperative peripheral nerve block with analgesic aim (infiltration of a local surgical anesthetic or transversus abdominis plane block-TAP block-authorized)
- arrhythmia or the presence of a pacemaker
- ambulatory surgery
- cardiac or cerebral surgery
- obstetrical surgery (caesarean)
- surgery performed with neuraxial regional anesthesia or peripheral anesthesia alone
- surgery performed in prone position
- urgent surgery
- endoscopic procedure or interventional radiology
- chronic pain treated with opiates
- expected surgery duration < 1h
- pathology of the autonomic nervous system (epilepsy, history of transient attack or stroke, paraplegia, hemiplegia, orthostatic hypotension, autonomic dysfunction)
- Patient with cardiogenic or septic shock
- Continuous infusion of vasoactive agents (ephedrine, phenylephrine, adrenaline, or noradrenaline)
- Postoperative transfer planned in intensive care unit (intubated patient) after surgery
- Person under tutorship or curatorship
- Pregnancy
- Breastfeeding
Sites / Locations
- CHU Clermont-FerrandRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
usual practice
targeted analgesia to ANI
control group (usual practice): patients receiving a general anesthesia with propofol, ketamine and remifentanil with or without curare for the induction, and desflurane and remifentanil (with or without curare) for the maintenance. The dosage of the anesthetic agent, as well as the prophylactic administration of morphine at the end of the intervention, will be decided by the anesthesiologist.
experimental group: patients receiving a general anesthesia with propofol, ketamine and remifentanil with or without curare for the induction, and desflurane and remifentanil (with or without curare) for the maintenance, as well as the prophylactic administration of morphine at the end of the intervention, will be administered according to the ANI. - In addition, desflurane will be administered with a targeted purpose of minimal alveolar concentration (MAC).